Studies in yeast and mice suggest that myosin V participates in the directed transport of a number of distinct cargos to polarized regions of the cell; myosin V has also been implicated in the provision of materials for filopodial extension in neurons. The myosins form a superfamily of motor proteins that generate directed movement along actin filaments in an ATP-dependent manner. The prototypical myosin was originally discovered as the major protein in muscle, and recent genetic and molecular biological studies have revealed a diverse family of myosin proteins that share a common motor domain, but have divergent carboxyterminal tail regions. The muscle-type myosins are referred to as either conventional or class II myosins; all the others (a total of twelve distinct classes so far) are collectively referred to as unconventional myosins [1] , each designated by a roman numeral based on their order of discovery. Our understanding of the roles of the unconventional myosins has lagged well behind that of the wellstudied myosin II, but rapid progress has recently been made in defining the in vivo functions of myosin V.
Myosin V was first identified in actomyosin precipitates from brain tissue [2] as a 190 kDa calmodulin-binding protein that exhibits all of the expected enzymatic properties of a myosin molecule, in that it has actin-stimulated Mg-ATPase activity and can generate directed movement along actin cables [3, 4] . Myosin V is actually an oligomer, comprising two ~190 kDa 'heavy chain' subunits and twelve low molecular weight subunits (light chains). The light chains bind to six IQ motifs in the neck region of each heavy chain, and the heads of the heavy chains are correspondingly elongated relative to those of myosin II [4] . Eight of the twelve myosin V light chains are calmodulin molecules, and the other four remain to be identified. The tail region of the myosin V heavy chain has a central coiled-coil domain that presumably promotes dimer formation followed by a globular domain. Unlike myosin II, myosin V does not appear to form filaments.
A range of roles for myosin V in yeast
The phenotypic defects observed in mice and yeast myosin V mutants strongly suggest that this motor protein plays a part in intracellular transport. There are two yeast class V myosins, Myo2p and Myo4p, each of which appears to have a distinct intracellular role. The temperature-sensitive Myo2p mutant, myo2-66, undergoes growth arrest with the formation of large unbudded cells at the restrictive temperature. The cell wall is also affected by the myo2-66 mutation, as evidenced by chitin delocalization [5] . Additionally, small vesicles of unknown origin are observed to accumulate in the mother cell [5, 6] , suggestive of a defect in vesicle transport. Cortical actin patches are still present, but they are uniformly distributed throughout the cell instead of being localized to the growing bud, and the actin cables appear to have coalesced into a prominent actin bar [5] .
The directed transport of Chs3p, a chitin synthase, to sites of polarized growth is also impaired in myo2-66 mutant cells, whereas that of another chitin synthase, Chs5p, is unaffected [7] , suggesting that myosin V is required for the directed transport of a distinct subset of molecules. The myo2-66 mutation additionally has profound effects on the inheritance of the vacuole (the yeast equivalent of the lysosome) [8] . The growing bud does not receive a vacuole from the mother cell, suggesting that Myo2p plays a role in the transport of this organelle into the bud [8] . All of these defects implicate Myo2p in the directed movement of distinct vesicles to the site of polarized growth in yeast. The phenotype of the mutant and the localization of Myo2p to the tip of growing bud [8] [9] [10] are both consistent with Myo2p either organizing the actin tracks at the tip or accumulating at the tip following its directed translocation along those filaments to the emerging bud. Surprisingly, yeast Myo4p appears to play a different role to Myo2p. Deletion of MYO4 does not result in any of the striking abnormalities found in the myo2-66 strain [11] . However, Myo4p is required for the asymmetric accumulation of the protein Ash1p in the growing bud [12] ; Ash1p represses the transcription of the HO gene, which is required to stop the switching of mating type. By preventing Ash1p transport to the bud, loss of Myo4p thus allows the daughter cell to express HO and switch mating types [12, 13] . The lack of alterations in either the actin cytoskeleton, the morphology or the growth of the myo4 cells demonstrates that Myo4p plays a specialized role in the directed transport of a component(s) required for regulating gene expression.
Myo4p is itself localized to the growing bud, and this localization is dependent on either She3p or Bni1p, proteins also implicated in the repression of HO expression in the emerging bud [13] , indicating that this myosin may be part of a complex of proteins that are targeted to the bud. Intriguingly, ASH1 mRNA is also localized to the growing bud in an Myo4p-dependent manner [14] , suggesting that Myo4p may participate in a specialized transport complex that is specific for the movement of mRNA molecules rather than proteins. Thus, even though Myo2p and Myo4p share many structural attributes, and have similar intracellular localizations [11, 13] , these two myosins clearly play distinct roles in directing the movement of membranes, molecules or mRNA within the yeast cell ( Fig. 1) .
A role for myosin V in melanocytes and the nervous system
There is a well-known mutant mouse where the defect has been shown to be in myosin V -this is the dilute mutant, which has a lightened coat color and dies of nervous seizures three weeks after birth [15, 16] . The overall structure of the brain from a dilute mouse appears to be normal, as does the morphology and cytoskeletal organization of superior cervical ganglion cells cultured from these mice [17] . These findings suggest that the defects in the dilute mice are the result of abnormalities in the intracellular function of their neurons. Support for this hypothesis has been provided by electron microscopic analysis of sections of brains from dilute mice, which have revealed that the usual extensions of the smooth endoplasmic reticulum into the dendritic spines of Purkinje cells are absent [18] . It has also been shown that myosin V is associated with synaptic vesicles [19] , and it is likely that this motor plays a role in the actin-dependent movement of membranes -possibly vesicles carrying neurotransmitters -to the extremities of neurons.
These findings echo the analyses of melanocytes cultured from dilute mice and the distribution of myosin V in normal melanocytes. The distribution of melanosomes is altered in primary cultures of dilute melanocytes, whereas the overall morphology of the cells appears normal [20] . Additionally, in wild-type mice myosin V colocalizes with melanosomes, as well as other membrane-bound organelles in normal melanocytes [20, 21] . Subcellular fractionation experiments also demonstrate that myosin V is associated with melanosomes [21] . Taken together, these observations suggest that myosin V functions in the directed movement of membrane-bound organelles in both neurons and melanocytes.
The known biochemical properties of myosins appear to be inconsistent with the view that myosin V plays a part in organelle transport. Detailed analyses of myosin I and II indicate that these proteins are 'short-duty' motors [22] , in other words, they are not processive motors, but are detached from actin for most of their ATP-hydrolysis cycle. Myosin I and II therefore differ from kinesin, a microtubule motor protein that spends most of its hydrolytic cycle bound to microtubules. The kinetic properties of kinesin permit it to function as a transport motor at the level of a single molecule, because it will not be released from its track during the hydrolysis cycle. A single myosin molecule, on the other hand, is likely to diffuse away from an actin filament under motile conditions. However, analysis of the enzymatic properties of myosin V reveals that it may have different kinetic properties from class I and II myosins. Unlike myosin I and II, a significant proportion of myosin V remains bound to actin in the presence of millimolar amounts of Mg-ATP [23] . This suggests that myosin V may be able to bind to actin for a significant amount of its hydrolysis cycle and function as a processive motor in a similar way to kinesin.
A novel approach to exploring myosin V function
The role of myosin V in growth cone and filopodial dynamics was explored in neuronal growth cones of the dorsal root ganglion (DRG) using micro-chromophoreassisted laser inactivation (CALI; [24] ). The results of this study suggest that myosin V has yet another function in vivo. The CALI technique allows for the immediate inactivation of a target protein in situ by microinjection of a non-inhibitory 'anti-target' antibody coupled to a chromophore (typically malachite green, MG) and subsequent application of a laser pulse at 620 nm. It is thought that the laser treatment results in the production of short-lived hydroxyl radicals from the MG chromophore, which then inflict damage to proteins in close proximity (presumably the target immunogen) without affecting neighboring proteins [25] . The efficacy of this method depends on the availability of a specific, non-inhibitory antibody and it is necessary to demonstrate first that CALI can inactivate the target protein in vitro.
Microinjection of MG-labelled myosin V antibodies into chick DRGs followed by laser irradiation had unpredicted effects [24] . The irradiated regions of the DRG were observed to exhibit significantly decreased rates of filopodial extension. During the period of laser irradiation of the DRGs, the filopodia were almost exclusively retracting; however, the rate of retraction in the treated growth cones did not significantly differ from that observed in untreated or mock-treated DRGs. Thus, the loss of myosin V only affects the extension of the filopodia, indicating that myosin V is providing materials that are specifically required for the extension of filopodia. This could be accomplished in a direct manner by feeding the necessary amounts of membrane to the peripheral regions of the cell or by indirectly transporting or stabilizing other molecules that are necessary for this process.
The CALI results are in apparent conflict with the finding that the overall brain structure in dilute mice is normal and that the superior cervical ganglion cells from these mice also appear to be normal in morphology and cytoskeletal distribution [16, 17] . This suggests that either the CALI method is not as specific in vivo as it appears to be in vitro, or the dilute mouse has been able to overcome what would be a catastrophic loss of myosin V by the altered expression of another cytoskeletal protein(s). A second mouse myosin V gene, myr6, has been identified [26] , and it is possible that altered expression of myr6 could compensate for the loss of the other myosin V in the dilute mice. However, even if expression of myr6 can substitute for the myosin V protein absent from the dilute mice, Myr6 does not appear to be capable of fulfilling all its functions, as evidenced by the defects in coat colour and the premature death by nervous seizures shown by the dilute phenotype.
The specificity of the CALI technique for its target proteins is illustrated by the fact that CALI of several different cytoskeletal proteins in DRGs has quite different effects. For example, CALI of myosin I␤ results in lamellipodial expansion but not filopodial retraction [24] . It is worth considering how CALI may inactivate the target protein in situ. In the case of myosin V, a specific antibody directed against the carboxy-terminal tail region was used. The MG-conjugated form of this antibody inactivated both the biochemical activity of purified myosin V and its ability to generate motility in vitro following irradiation [24] . But how could the antibody directed against the tail region of myosin V inactivate the activity of the motor domain? This remains to be determined, but it is unlikely that this occurs by irradiation-induced cleavage of the Dispatch R303
Figure 2
The inactivation of myosin V by CALI in the nerve growth-cone. This figure shows a nerve growth-cone and the distribution of selected cytoskeletal elements (microtubules, actin and myosin V). The terminus of the growth cone is rich in actin, and the central region is predominantly composed of microtubules. Myosin V can attach to vesicles that are carried along the microtubules by kinesin, with myosin V acting as a passenger (1); and myosin V can also be found in the periphery of the nerve attached to a vesicle (2). Microinjection of chromophore-labeled antimyosin V antibody followed by irradiation of the growth cone would presumably disrupt myosin V function exclusively at the outermost portions of the growth cone (2) . Alternatively, the myosin V tail could be in close proximity to the presumptive microtubule motor, the function of which would then also be affected following irradiation (3). heavy chain. Also, if myosin V is present as part of a 'transport complex', it is not possible to rule out the possibility that the antibody can inactivate another protein that is in close enough proximity to the tail of myosin V (which is presumably binding to the cargo) to be affected by the CALI treatment (Fig. 2) . The observation that myosin Vassociated vesicles are localized to microtubules in addition to actin filaments [17] suggests that this may be the case. Myosin V could be a passive cargo on kinesin-transported vesicles and, if the MG-antibody were close enough, it could also damage the microtubule-based transport system that routes material to the extending growth cone. While many interesting questions remain, it is clear that the CALI effect is specific and that myosin V is either directly involved or in intimate contact with proteins that play a key role in the extension of filopodia.
Taken together, the collective analyses of myosin V strongly implicate this unconventional myosin in the directed delivery of material to the periphery of cells. Whether this material is exclusively in the form of a membrane-bound organelle, a complex of proteins or even mRNA molecules, remains to be determined. The mounting evidence suggests that myosin V participates in the transport of a wide range of materials and that it may not be a 'dedicated' motor protein, that is, it may not be restricted to the movement of one specific class of molecules or organelles. It is also needs to be clearly established whether myosin V is directly transporting these materials or if it is organizing the state of the underlying actin cytoskeleton to facilitate or optimize the transport of the materials by other proteins. The next step is to characterize myosin V's partners in crime -tail-binding proteins that anchor myosin V either to its cargo or to its intracellular location. The identification of distinct membrane-bound organelles that possess myosin V [19, 21] , the ability to obtain biochemical quantities of this protein [3, 4] and the availability of myosin V mutants in a genetically tractable system [5, 13, 16] hold the promise of rapid progress towards this goal.
